Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HS10241 |
Synonyms | |
Therapy Description |
HS10241 is a MET inhibitor that blocks the activation of Met, which potentially inhibits downstream signaling and induces cytotoxicity (PMID: 30949414). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HS10241 | HS-10241 | MET Inhibitor 59 | HS10241 is a MET inhibitor that blocks the activation of Met, which potentially inhibits downstream signaling and induces cytotoxicity (PMID: 30949414). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|